Metavert, a novel cancer chemotherapeutic has shown to prevent cancer metastasis. The study has been carried out in an animal model and its establishment in human trials would revolutionize treatment for metastatic cancer of the pancreas. Pancreatic cancer is one of the most lethal type of cancer in the world. The incidence of pancreatic cancer increases each year with no significant decrease in its mortality.
Among all the cases of cancer, the most significant is the occurrence of pancreatic ductal adenocarcinoma (PDCA). To add on to this crisis, there is a manifestation of drug resistance which hinders the action of standardized PDCA drug regimen. Researchers from Cedars-Sinai Medical Center in California have developed a drug that can halt cancer metastasis and also solve the problem of drug resistance in PDCA patients. Additionally, Metavert significantly boosted effects of…
